Posted by ABMN Staff on May 3rd, 2024
AbbVie Inc. (NYSE:ABBV – Free Report) – Equities researchers at Leerink Partnrs increased their Q2 2024 earnings per share estimates for AbbVie in a research report issued on Monday, April 29th. Leerink Partnrs analyst...
More of this article »